FBLG - Company ID 0001958777
The table below shows FibroBiologics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.52M | $1.48M | $4.87M | $8.85M | $8.67M | $7.83M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.85M |
| $2.90M |
| $5.24M |
| $10.18M |
| $9.33M |
| $8.20M |
| Property, plant & equipment | $710.00K | $776.00K | $908.00K | $967.00K | $814.00K | $772.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $7.93M | $5.94M | $8.74M | $13.91M | $11.43M | $10.47M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.21M | $1.83M | $6.72M | $10.96M | $8.21M | $6.68M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.29M | $3.34M | $8.62M | $13.05M | $9.08M | $7.73M |
| Retained earnings | -$63.28M | -$59.16M | -$50.92M | -$45.14M | -$40.48M | -$32.42M |
| Total equity | $4.64M | $2.60M | $125.00K | $860.00K | $2.35M | $2.74M |